<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04816500</url>
  </required_header>
  <id_info>
    <org_study_id>Capital Medical U</org_study_id>
    <nct_id>NCT04816500</nct_id>
  </id_info>
  <brief_title>Remote Ischemic Conditioning on Cerebral Small Vessel Disease</brief_title>
  <acronym>RIC-SVD</acronym>
  <official_title>Study of Efficacy and Safety of Remote Ischemic Conditioning on Cerebral Small Vessel Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Capital Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Capital Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial is a randomized, controlled, single-center, double-blind trial. Cerebral small&#xD;
      vessel disease (CSVD) patients will be recruited and randomized into RIC or control group.The&#xD;
      protective effect of remote ischemic conditioning (RIC) on CSVD will be investigated.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes of volume of WMHs</measure>
    <time_frame>From baseline to 1 year treatment</time_frame>
    <description>The volume of WMHs was measured on Flairs and DTI. By calculating the mean diffusivity (MD) and FA of water diffusion, DTI can assess the integrity and connectivity of WM tissue from a network perspective, and reconstruct the distribution of WM pathways in the brain three-dimensionally.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in hemodynamic parameters on TCD.</measure>
    <time_frame>From baseline to 1 year treatment</time_frame>
    <description>The peak systolic, mean, and end diastolic blood flow velocities (BFV) at the most proximal segment of bilateral MCAs, BA were measured by TCD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of cognition evaluation on MoCA.</measure>
    <time_frame>From baseline to 1 year treatment</time_frame>
    <description>The Beijing version of MoCA were used to evaluate to evaluate the cognitive functions of patients, referring to the degree of an individual's capacity with respect to orientation, memory, calculation, language, execution and visuospatial function and so on</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Cerebral Small Vessel Diseases</condition>
  <arm_group>
    <arm_group_label>RIC group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Device: Remote ischemic conditioning RIC is a non-invasive therapy that performed by an electric autocontrol device with cuff placed on arm. RIC procedures consist of five cycles of 5-min inflation (200 mmHg) and 5-min deflation of cuff on one arm. The procedure will be performed twice daily for consecutive 1 year after enrollment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Regular treatment</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Automatic ischemic conditioning treatment instrument</intervention_name>
    <description>RIC is a non-invasive therapy that performed by an electric autocontrol device with cuff placed on arm. RIC procedures consist of five cycles of 5-min inflation (200 mmHg) and 5-min deflation of cuff on one arm. The procedure will be performed twice daily for consecutive 1 year after enrollment.</description>
    <arm_group_label>RIC group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Regular treatment</intervention_name>
    <description>Antiplatelet agents and statins administration, vascular risk factors control.</description>
    <arm_group_label>Regular treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. 45-80 years old, and gender not limited;&#xD;
&#xD;
          2. patient and/or caregiver report of cognitive declines with regard to memory and/or&#xD;
             other cognitive domains lasting for at least 3 months;&#xD;
&#xD;
          3. neither normal nor demented on the basis of the criteria of the Diagnostic and&#xD;
             Statistical Manual of Mental Disorders (Fourth Edition) with normal or slightly&#xD;
             impaired activities of daily living9, with Mini-mental State Examination (MMSE) score&#xD;
             ≥ 20 (primary school) or ≥ 24 (junior school or above)10 and Montreal Cognitive&#xD;
             Assessment (MoCA) score ≤ 26;&#xD;
&#xD;
          4. the presence of lacunes and/or WMHs and/or CMBs on MRI&#xD;
&#xD;
          5. absence of vascular narrowing &gt;50% luminal diameter that could cause hemodynamic&#xD;
             changes (MFV&gt;90 cm/s for the intracranial internal carotid artery, 100 cm/s for MCA,&#xD;
             &gt;80 cm/s for basilar artery [BA] or vertebral artery) measured by TCD&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. clinical manifestations indicating that the patient was at the end-stage of cSVD;&#xD;
&#xD;
          2. hereditary or inflammatory small vessel disorders&#xD;
&#xD;
          3. cerebral venous injury or changes;&#xD;
&#xD;
          4. diagnosis of nervous system degenerative diseases Alzheimer's disease, DLB,&#xD;
             frontotemporal dementia (FTD), and so on;&#xD;
&#xD;
          5. history of intracranial hemorrhage or significant bleeding in other parts of the body&#xD;
&#xD;
          6. brain tumor, psychoses, or acute stroke within 6 months;&#xD;
&#xD;
          7. cardiogenic embolism;&#xD;
&#xD;
          8. significant bleeding coagulation dysfunction;&#xD;
&#xD;
          9. serious liver and kidney function is not complete, malignant tumor, or serious&#xD;
             diseases need to medical intervention or surgery;&#xD;
&#xD;
         10. any soft tissue or vascular injury, and any disease of the extremities that may&#xD;
             contraindicate RIC;&#xD;
&#xD;
         11. pregnant women;&#xD;
&#xD;
         12. life expectancy&lt;6 months;&#xD;
&#xD;
         13. refused to sign a consent form, poor compliance, or not to cooperate to complete whole&#xD;
             treatment, and so on.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yuan Wang, MD</last_name>
    <phone>+861083199085</phone>
    <email>wilma0106@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Xuanwu hospital;Capital Medical University</name>
      <address>
        <city>Beijin</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xunming Ji</last_name>
      <phone>+86-10-83198952</phone>
      <email>jixunming@vip.163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 23, 2021</study_first_submitted>
  <study_first_submitted_qc>March 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 25, 2021</study_first_posted>
  <last_update_submitted>March 23, 2021</last_update_submitted>
  <last_update_submitted_qc>March 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Capital Medical University</investigator_affiliation>
    <investigator_full_name>Ji Xunming,MD,PhD</investigator_full_name>
    <investigator_title>Study of Efficacy and Safety of remote ischemic conditioning on cerebral small vessel disease</investigator_title>
  </responsible_party>
  <keyword>Cerebral Small Vessel Diseases</keyword>
  <keyword>Remote Ischemic Conditioning</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cerebral Small Vessel Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

